Wednesday, July 8, 2026

pharma · Colorectal Cancer · Cancer · GDTC

CytoMed Therapeutics

CytoMed Therapeutics is a pharma organization headquartered in 1 COMMONWEALTH LANE, U0, SG. It trades on NYSE under ticker GDTC. Primary therapeutic focus areas include Colorectal Cancer, Cancer, Aging Well, Lupus Nephri

1 COMMONWEALTH LANE, U0, SG HQ
2018 Founded
26 Employees
Public company Type
GDTC · NYSE Ticker
Company details
Status
Public
HQ
1 COMMONWEALTH LANE, U0, SG
Founded
2018
Employees
26
Programs
4
Drugs
12
Patents
3
Clinical program

Human Umbilical Cord derived MSCs

Phase 2 · mab · Lupus Nephritis

Human Umbilical Cord derived MSCs for Lupus Nephritis is a Phase 2 program (mab) at CytoMed Therapeutics Ltd with 1 ClinicalTrials.gov record(s).

Internal code CT 11-03

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
CytoMed Therapeutics Ltd
Phase
Phase 2
Modality
mab
Indication
Lupus Nephritis
Status
active
Trials
1